Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Rein TherapeuticsRNTX | Open-market buy | 05/21–05/27 | 05/28 | 47,060 sh4 trades | $1.06avg. | $49,700.7 | +304.5% | |
James Brian WindsorSEE REMARKS | Rein TherapeuticsRNTX | Open-market buy | 04/30 | 05/13 | 25,000 sh | $1.00 | $25,000 | +1221.9% |
Voss Capital10% Owner | Rein TherapeuticsRNTX | Open-market buy | 25/11/14 | 25/11/18 | 104,183 sh | $1.22 | $127,103.26 | +12.7% |
Rein TherapeuticsRNTX | Open-market buy | 25/10/24–25/10/28 | 25/10/28 | 306,050 sh4 trades | $1.38avg. | $423,459.86 | +157.8% |